These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The market in diabetes. Hauber A; Gale EA Diabetologia; 2006 Feb; 49(2):247-52. PubMed ID: 16416145 [No Abstract] [Full Text] [Related]
5. Forging paths to improve diabetes care in low-income settings. The Lancet Diabetes Endocrinology Lancet Diabetes Endocrinol; 2017 Aug; 5(8):565. PubMed ID: 28732660 [No Abstract] [Full Text] [Related]
6. The Insulin Boom. WHY THE COST OF THIS LIFESAVING DRUG IS REACHING NEW HEIGHTS. Tsai A Diabetes Forecast; 2016; 69(2):32-7. PubMed ID: 27048046 [No Abstract] [Full Text] [Related]
7. Economics of insulin. Shah SN J Assoc Physicians India; 2007 Jul; 55 Suppl():67-70. PubMed ID: 17927015 [No Abstract] [Full Text] [Related]
8. Inhaled insulin: gone with the wind? Mathieu C; Gale EA Diabetologia; 2008 Jan; 51(1):1-5. PubMed ID: 18026925 [No Abstract] [Full Text] [Related]
12. [Insulin analogues--which dimension should be discussed?]. Verspohl EJ Med Monatsschr Pharm; 2006 Jun; 29(6):198-9. PubMed ID: 16792195 [No Abstract] [Full Text] [Related]
13. Diabetes costs rise, but so does adherence. Manag Care; 2005 Apr; 14(4):54. PubMed ID: 15898213 [No Abstract] [Full Text] [Related]
14. PHARMAC and long-acting insulin analogues: a poor man's insulin pump--but not available to the poor man. Krebs J N Z Med J; 2005 Aug; 118(1221):U1641. PubMed ID: 16138177 [TBL] [Abstract][Full Text] [Related]
15. Diabetes in the developing world. Lakhani Z BMJ; 1995 Feb; 310(6976):403. PubMed ID: 7866240 [No Abstract] [Full Text] [Related]
16. Biosimilars for insulin: a cost-saving alternative? McCall C Lancet; 2018 Aug; 392(10146):463-464. PubMed ID: 30129449 [No Abstract] [Full Text] [Related]
17. Diabetes research investment in the European Union. Halban PA; Ferrannini E; Nerup J Nat Med; 2006 Jan; 12(1):70-2. PubMed ID: 16397573 [No Abstract] [Full Text] [Related]